Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Rosuvastatin Mylan
Active Ingredient:	Rosuvastatin calcium 5.21mg equivalent to rosuvastatin 5mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Medreich Limited, Poojaramanahalli Village, India

*Product:*	Rosuvastatin Mylan
Active Ingredient:	Rosuvastatin calcium 10.42mg equivalent to rosuvastatin 10mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Medreich Limited, Poojaramanahalli Village, India

*Product:*	Rosuvastatin Mylan
Active Ingredient:	Rosuvastatin calcium 20.84mg equivalent to rosuvastatin 20mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Medreich Limited, Poojaramanahalli Village, India

*Product:*	Rosuvastatin Mylan
Active Ingredient:	Rosuvastatin calcium 41.68mg equivalent to rosuvastatin 40mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Medreich Limited, Poojaramanahalli Village, India

Dated this 9th day of June 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule